---
title: "HealthStream | 10-Q: FY2025 Q3 Revenue Beats Estimate at USD 76.47 M"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/264740083.md"
datetime: "2025-11-06T23:06:34.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/264740083.md)
  - [en](https://longbridge.com/en/news/264740083.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/264740083.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/264740083.md) | [繁體中文](https://longbridge.com/zh-HK/news/264740083.md)


# HealthStream | 10-Q: FY2025 Q3 Revenue Beats Estimate at USD 76.47 M

Revenue: As of FY2025 Q3, the actual value is USD 76.47 M, beating the estimate of USD 75.52 M.

EPS: As of FY2025 Q3, the actual value is USD 0.2, beating the estimate of USD 0.172.

EBIT: As of FY2025 Q3, the actual value is USD 6.805 M.

### Segment Revenue

-   **Subscription Services**: Revenue increased by 6% to $73.9 million for the three months ended September 30, 2025, compared to $69.9 million for the same period in 2024. For the nine months ended September 30, 2025, subscription services revenue was $216.6 million, up 4% from $209.1 million in 2024.
-   **Professional Services**: Revenue decreased by 19% to $2.6 million for the three months ended September 30, 2025, compared to $3.2 million for the same period in 2024. For the nine months ended September 30, 2025, professional services revenue was $7.7 million, down 6% from $8.3 million in 2024.

### Operational Metrics

-   **Net Income**: Net income for the three months ended September 30, 2025, was $6.1 million, a 6.3% increase from $5.7 million in the same period in 2024. For the nine months ended September 30, 2025, net income was $15.8 million, compared to $15.1 million in 2024.
-   **Operating Income**: Operating income for the third quarter of 2025 was $7.6 million, up 16.5% from $6.5 million in the third quarter of 2024.
-   **Adjusted EBITDA**: Adjusted EBITDA for the third quarter of 2025 was $19.1 million, a 7.9% increase from $17.7 million in the third quarter of 2024. For the nine months ended September 30, 2025, adjusted EBITDA was $52.9 million, compared to $50.6 million in 2024.

### Cash Flow

-   **Operating Cash Flow**: Net cash provided by operating activities was $50.1 million for the nine months ended September 30, 2025, compared to $46.5 million for the same period in 2024.
-   **Investing Activities**: Net cash used in investing activities was $27.0 million for the nine months ended September 30, 2025, compared to $25.9 million in 2024.
-   **Financing Activities**: Net cash used in financing activities was $29.0 million for the nine months ended September 30, 2025, compared to $3.5 million in 2024.

### Unique Metrics

-   **Capital Expenditures**: Capital expenditures were $7.5 million for the three months ended September 30, 2025, compared to $6.8 million for the same period in 2024. For the nine months ended September 30, 2025, capital expenditures were $25.4 million, compared to $21.3 million in 2024.

### Future Outlook and Strategy

-   **Core Business Focus**: HealthStream, Inc. plans to continue leveraging its hStream technology platform to enhance interoperability among its SaaS applications, aiming to improve business and clinical outcomes for healthcare organizations. The company is focused on expanding its provider data management and credentialing solutions, as evidenced by the acquisition of Virsys12.
-   **Non-Core Business**: The company has subleased a portion of its office space to optimize workforce performance and expects to generate sublease income of approximately $3.2 million annually.

### Related Stocks

- [HealthStream, Inc. (HSTM.US)](https://longbridge.com/en/quote/HSTM.US.md)

## Related News & Research

- [Virsys12® Named a Leader in the IDC MarketScape: U.S. Provider Data Management for Payers 2025–2026 Vendor Assessment | HSTM Stock News](https://longbridge.com/en/news/280639754.md)
- [Australia to consider using a mechanism if there is a gas shortfall in Q3](https://longbridge.com/en/news/281420207.md)
- [Cintas (CTAS) Valuation Check After Q3 Results And Higher Fiscal 2026 Guidance](https://longbridge.com/en/news/281225115.md)
- [Nike Takes 'Intentional' Hit To Clear 'Unhealthy Inventory' In Q3 As CEO Eyes Turnaround By Year-End](https://longbridge.com/en/news/281362844.md)
- [Nike Delivers Q3 Earnings Beat As Turnaround Progresses, Shares Slide](https://longbridge.com/en/news/281243092.md)